1
Baak, Lisanne M., Wagenaar, Nienke, van der Aa, Niek E., Groenendaal, Floris, Dudink, Jeroen, Tataranno, Maria Luisa, Mahamuud, Ubah, Verhage, Cornelia H., Eijsermans, Rian M.J.C., Smit, Liesbeth S., Jellema, Reint K., de Haan, Timo R., ter Horst, Hendrik J., de Boode, Willem P., Steggerda, Sylke J., Prins, Henk Jan, de Haar, Colin G., de Vries, Linda S., van Bel, Frank, Heijnen, Cobi J., Nijboer, Cora H., Benders, Manon J.N.L.
Veröffentlicht in: Baak , L M , Wagenaar , N , van der Aa , N E , Groenendaal , F , Dudink , J , Tataranno , M L , Mahamuud , U , Verhage , C H , Eijsermans , R M J C , Smit , L S , Jellema , R K , de Haan , T R , ter Horst , H J , de Boode , W P , Steggerda , S J , Prins , H J , de Haar , C G , de Vries , L S , van Bel , F , Heijnen , C J , Nijboer , C H & Benders , M J N L 2022 , ' Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN) : a first-in-human, open-label intervention study ' , The Lancet Neurology , vol. 21 , no. 6 , pp. 528-536 . https://doi.org/10.1016/S1474-4422(22)00117-X;
2022
Veröffentlicht in: Baak , L M , Wagenaar , N , van der Aa , N E , Groenendaal , F , Dudink , J , Tataranno , M L , Mahamuud , U , Verhage , C H , Eijsermans , R M J C , Smit , L S , Jellema , R K , de Haan , T R , ter Horst , H J , de Boode , W P , Steggerda , S J , Prins , H J , de Haar , C G , de Vries , L S , van Bel , F , Heijnen , C J , Nijboer , C H & Benders , M J N L 2022 , ' Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN) : a first-in-human, open-label intervention study ' , The Lancet Neurology , vol. 21 , no. 6 , pp. 528-536 . https://doi.org/10.1016/S1474-4422(22)00117-X;
2022